Markovic D, Markovic-Zivkovic B and Jankovic RJ
Trigeminal neuralgia continues to be a remarkable therapeutic problem especially if the pain becomes chronic. If that happens the quality of patient’s life decreases and there is a high risk for the patients to develop depression and other psychiatric disorders. The primary approach is pharmacological. However, about 75% of patients respond well to pharmacotherapy and in others it remains without result. In some patients the pain becomes refractory after a while, while some patients manifest adverse effects. Many invasive and non-invasive therapeutic methods have been developed, each with advantages and disadvantages. Every patient should be approached with extreme seriousness, and a decision should be made individually.
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Telugu